Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
NexMed is developing RayVaTM, a topical treatment for Raynaud’s syndrome and incorporates alprostadil with the NexACT® proprietary permeation enhancer (DDAIP.HCL). More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Development of a Cellular and Animal Model for Infantile Haemangioma More
Blood Group Genotyping: Primers for RHD and ABO Gene Amplification More
Pravastatin Production Technology: Use in the Treatment of Cardiovascular Disease More
Improvement on Current Electronic Stethoscopes: Separation of Foetal Phonocardiograms of a Multi-Foetal Pregnancy More
Affinity Purified Heparin: Separating the Anticoagulant Activity of Heparin More
Implantable Monitoring of Vital Functions Real Time Monitoring and Therapy: The Vitamon Monitor More
TERSE: Transmission and Emission Reconstruction Software Environment More
An in-vitro Model for Therapeutic Testing Following Cardiac Injury More
Related Reports
Market Research Reports provided by reports.innovaro.com
Nov 2010 - 40 pages - $500
Nov 2010 - 330 pages - $1,495
Jul 2010 - 20 pages - $750
May 2011 - 23 pages - $125
Mar 2011 - 6 pages - $500
May 2011 - 15 pages - $125
Sep 2010 - 25 pages - $125
Mar 2008 - 250 pages - $3,995
May 2011 - 396 pages - $2,265
Dec 2010 - 42 pages - $1,000
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Blood composition
- Blood disorders
- Blood substitute
- Blood Transfusion
- Fibrogenesis
- Hemorrhagic trauma
- Lymphatic disorders
- Sepsis
- Thrombosis
- Whole blood substitute
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us